Comparing Ogivri vs Taxotere
Ogivri | Taxotere |
|
---|
Ogivri (trastuzumab) | Taxotere (docetaxel) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Breast Cancer - Adjuvant, Breast Cancer - Metastatic, Breast Cancer, Esophageal Carcinoma, Gastric Cancer. Ogivri may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Prostate Cancer, Breast Cancer, Non Small Cell Lung Cancer, Breast Cancer - Metastatic, Gastric Cancer, Head and Neck Cancer. Taxotere may also be used for purposes not listed in this... View more |
Related suggestions Gastric Cancer
|
|||||||
More about Ogivri (trastuzumab) | More about Taxotere (docetaxel) | ||||||||
Ratings & Reviews | |||||||||
Be the first to share your experience with this drug. |
Taxotere has an average rating of 5.2 out of 10 from a total of 11 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 50% reported a negative effect. |
||||||||
Drug Class | |||||||||
Side Effects | |||||||||
See also: Ogivri side effects in more detail. |
See also: Taxotere side effects in more detail. |
||||||||
Generic Availability | |||||||||
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Ogivri prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms Available | |||||||||
|
|
||||||||
Brand Names | |||||||||
Other trastuzumab brands include: Herceptin, Hercessi, Herzuma, Kanjinti, Ontruzant, Trazimera | Other docetaxel brands include: Docivyx | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||
924 hours |
11.1 hours |
||||||||
CSA Schedule ** View glossary of terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 171 drugs are known to interact with Ogivri:
|
A total of 477 drugs are known to interact with Taxotere:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
N/A |
May 14, 1996 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.